尹麗麗
?
不同時(shí)相醒腦開竅針刺法治療腦梗死及其對(duì)同型半胱氨酸的影響
尹麗麗
(天津中醫(yī)藥大學(xué)第一附屬醫(yī)院,天津 300193)
觀察不同時(shí)相進(jìn)行醒腦開竅針刺治療對(duì)腦梗死患者恢復(fù)及同型半胱氨酸的影響。將120 例腦梗死伴高同型半胱氨酸血癥患者分為急性期治療組、恢復(fù)期治療組和對(duì)照組,每組40例。急性期治療組于發(fā)病開始即行針刺治療,恢復(fù)期治療組于發(fā)病14 d后進(jìn)行針刺治療,對(duì)照組則不行針刺治療。3組患者均于發(fā)病時(shí)及發(fā)病1個(gè)月時(shí)測定血同型半胱氨酸水平(Hcy)及神經(jīng)功能缺損評(píng)分(NIHSS量表)。3組治療后血清Hcy水平及NIHSS評(píng)分與同組治療前比較,差異均具有統(tǒng)計(jì)學(xué)意義(<0.05)。急性期治療組、恢復(fù)期治療組治療后血清Hcy水平及NIHSS評(píng)分與對(duì)照組比較,差異均具有統(tǒng)計(jì)學(xué)意義(<0.05)。急性期治療組治療后血清Hcy水平及NIHSS評(píng)分與恢復(fù)期治療組比較,差異均具有統(tǒng)計(jì)學(xué)意義(<0.05)。針刺治療可有效降低腦梗死患者血Hcy水平,且不同時(shí)間點(diǎn)針刺有差異,早期治療效果更明顯。
針刺療法;腦梗死;醒腦開竅;同型半胱氨酸
腦梗死是臨床上常見疾病,病死率及致殘率均較高,嚴(yán)重危害人類健康。研究證實(shí),高同型半胱氨酸血癥是腦梗死一個(gè)新的獨(dú)立危險(xiǎn)因素,與腦梗死的發(fā)生、發(fā)展及嚴(yán)重程度有關(guān)[1]。針灸治療腦血管病歷史悠久,療效確切,但其機(jī)制未明[2-4]。本文通過觀察不同時(shí)相針刺治療腦梗死,并測定治療前后血清同型半胱氨酸(Hcy)水平變化,探討其可能機(jī)制,現(xiàn)報(bào)告如下。
120例腦梗死患者均為2011年1月至2011年6月天津中醫(yī)藥大學(xué)第一附屬醫(yī)院針灸科住院患者,隨機(jī)分為急性期治療組、恢復(fù)期治療組和對(duì)照組,每組40例。3組患者性別、年齡、Hcy值及神經(jīng)功能缺損評(píng)分(NIHSS)比較,差異均無統(tǒng)計(jì)學(xué)意義(>0.05),具有可比性。詳見表1。
依據(jù)1995年第四次腦血管病學(xué)術(shù)會(huì)議修訂的《各類腦血管疾病診斷要點(diǎn)》關(guān)于腦梗死的診斷標(biāo)準(zhǔn),結(jié)合影像檢查結(jié)果確診[5]。
①嚴(yán)重智能障礙不能完成配合者;②妊娠或哺乳期婦女;③合并有心、肺、肝、腎、造血系統(tǒng)、內(nèi)分泌系統(tǒng)等嚴(yán)重原發(fā)病及精神疾患者。
表1 3組患者一般資料比較
3組患者均給予基礎(chǔ)治療,如脫水,降顱壓、抗血小板、控制血壓、血糖、血脂,維持水電解質(zhì)平衡及對(duì)癥支持治療等。急性期治療組于發(fā)病開始即行針刺治療,恢復(fù)期治療組于發(fā)病14 d后開始針刺治療,對(duì)照組則不行針刺治療。
針刺治療取內(nèi)關(guān)、水溝、三陰交、極泉、尺澤、委中、風(fēng)池、完骨、天柱穴。內(nèi)關(guān)穴直刺0.5~1寸,采用提插捻轉(zhuǎn)瀉法,施手法1 min;水溝穴向鼻中隔方向斜刺0.3~0.5寸,采用雀啄瀉法,以流淚或眼球濕潤為度,每2~3 d針刺1次;三陰交穴沿脛骨后緣與皮膚呈45°角斜刺,進(jìn)針1~1.5寸,行提插補(bǔ)法,使患者下肢抽動(dòng)3次為度;極泉穴直刺1~1.5寸,用提插補(bǔ)法,使患者上肢抽動(dòng)3次為度;尺澤取穴時(shí),使患者屈肘120°,直刺1寸,采用提插補(bǔ)法,使患者前臂手指抽動(dòng)3次為度;委中穴采用提插瀉法,使患者下肢抽動(dòng)3次為度;針刺風(fēng)池穴時(shí),針向?qū)?cè)眼睛方向,震顫進(jìn)針0.5~1寸,施小幅度高頻率捻轉(zhuǎn)補(bǔ)法,施手法1 min;完骨、天柱兩穴操作同風(fēng)池穴。針刺治療每日1次,10 d為1個(gè)療程,共治療3個(gè)療程。
3組患者均于入院24 h內(nèi)及發(fā)病1個(gè)月時(shí),晨起空腹抽靜脈血測定血清Hcy及測定NIHSS評(píng)分。
采用SPSS14.0統(tǒng)計(jì)軟件進(jìn)行處理,計(jì)量資料以均數(shù)±標(biāo)準(zhǔn)差表示,采用檢驗(yàn)。
表2 3組患者治療前后血清Hcy水平及NIHSS評(píng)分比較(n=40)(±s)
注:與同組治療前比較1)<0.05;與對(duì)照組比較2)<0.05;與恢復(fù)期治療組比較3)<0.05
由表2可見,3組治療后血清Hcy水平及NIHSS評(píng)分與同組治療前比較,差異均具有統(tǒng)計(jì)學(xué)意義(<0.05)。急性期治療組、恢復(fù)期治療組治療后血清Hcy水平及NIHSS評(píng)分與對(duì)照組比較,差異均具有統(tǒng)計(jì)學(xué)意義(<0.05)。急性期治療組治療后血清Hcy水平及NIHSS評(píng)分與恢復(fù)期治療組比較,差異均具有統(tǒng)計(jì)學(xué)意義(<0.05),提示急性期治療組治療后改善血清Hcy水平及NIHSS評(píng)分優(yōu)于恢復(fù)期治療組。
血清Hcy是人體必需氨基酸蛋氨酸循環(huán)和半胱氨酸代謝過程中的一個(gè)重要中間產(chǎn)物。近年來大量研究證實(shí)同型半胱氨酸水平升高與心腦血管疾病發(fā)病高度相關(guān),降低血漿Hcy水平可能緩解Hcy導(dǎo)致的組織器官損傷。服用B族維生素和葉酸可能有利于降低Hcy,且這種治療策略已經(jīng)廣泛被臨床所應(yīng)用,但其確切劑量尚不明確,療效亦需進(jìn)一步觀察[6]。
醒腦開竅針刺法治療腦梗死療效確切,可清除氧自由基,改善紅細(xì)胞攜氧能力,改善大腦的血液供應(yīng),增加腦組織血流[7],有利于腦梗死恢復(fù)。研究表明,針刺治療介入時(shí)間越早,患者預(yù)后越好,因此我們倡導(dǎo)積極建立中風(fēng)單元,開辟中風(fēng)患者治療綠色通道,早期即開始針刺治療,以利于患者神經(jīng)功能缺損的恢復(fù)。本研究提示針刺可明顯降低血清同型半胱氨酸水平,且急性期針刺較恢復(fù)期針刺降低幅度更大,提示這可能是早期針刺有效性的機(jī)理之一。
[1] 劉梅,劉洪濤,李小剛.高同型半胱氨酸血癥與缺血性腦血管病的研究進(jìn)展[J].中風(fēng)與神經(jīng)疾病雜志,2005,22(4):379-381.
[2] Chen W, Gu HW, Ma WP,. Influence of acupuncture on cerebral vasomotoricity of ischemic stroke[J]. J Acupunct Tuina Sci, 2007, 5(1):32-34.
[3] Zhang L, Ge LB, Chen LF,. Clinical study on early acupuncture for acute ischemic stroke[J]. J Acupunct Tuina Sci, 2008, 6(4):222-226.
[4] Ge LB, Su XL, Zheng P,. Clinical research of acute stroke treatment using acupuncture[J]. J Acupunct Tuina Sci, 2008, 6(5):304-306.
[5] 中華醫(yī)學(xué)會(huì)神經(jīng)科分會(huì).各類腦血管疾病診斷要點(diǎn)[J].中華神經(jīng)科雜志,1996,29(6):379-380.
[6] 程絲,馮娟,王憲.高同型半胱氨酸血癥治療研究進(jìn)展[J].生理科學(xué)進(jìn)展,2011,42(5):329-334.
[7] 石學(xué)敏,楊兆鋼,周繼增,等.針刺治療假性延髓麻痹325例臨床和機(jī)理研究[J].中國針灸,1999,19(8):491-494.
Different-time Brain-activating and Orifice-opening Acupuncture Treatments for Cerebral Infarction and Their Effects on Homotype Cysteine
-.
,300193,
To investigate the rehabilitating effects of different-time brain-activating and orifice-opening acupuncture treatments on cerebral infarction and their impacts on homotype cysteine.One hundred and twenty cerebral infarction patients with hypercysteinemia were randomly allocated to acute stage treatment, convalescent stage treatment and control groups, 40 cases each. The acute stage treatment group received acupuncture at the onset of the disease, the convalescent stage treatment group received acupuncture at 14 days after the onset of the disease and the control group did not receive acupuncture treatment. Blood homotype cysteine levels were measured and neurological deficits were scored (using the NIHSS) in the three groups at the onset of the disease and at one month after the onset of the disease.There were statistically significant pre-/post-treatment differences in serum homotype cysteine (Hcy) levels and the National Institute of Health Stroke Scale (NIHSS) score in the three groups (<0.05). There were statistically significant post-treatment differences in serum Hcy levels and the NIHSS score between the acute stage or convalescent stage treatment group and the control group (<0.05). There were statistically significant post-treatment differences in serum Hcy levels and the NIHSS score between the acute stage treatment group and the convalescent stage treatment group (<0.05).Acupuncture treatment can effectively reduce blood homotype cysteine levels in cerebral infarction patients. Different time acupuncture produces a different effect. Early stage treatment has a better effect.
Acupuncture therapy; Cerebral infarction; Brain-activating and orifice-opening; Homotype cysteine
1005-0957(2013)01-0007-02
R246.6
A
10.3969/j.issn.1005-0957.2013.01.007
2012-08-24
尹麗麗(1980 - ),女,主治醫(yī)師